Tooth and ConsequencesMELAKOPOULOS, Ioannis; KARAGEORGOPOULOS, Drosos E; CHRISTODOULOU, Christos et al.The American journal of medicine. 2008, Vol 121, Num 7, pp 577-579, issn 0002-9343, 3 p.Article

Temozolomide for the treatment of brain metastases associated with metastatic melanoma: A phase II studyAGARWALA, Sanjiv S; KIRKWOOD, John M; GORE, Martin et al.Journal of clinical oncology. 2004, Vol 22, Num 11, pp 2101-2107, issn 0732-183X, 7 p.Article

Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II StudyCHRISTODOULOU, Christos; BAFALOUKOS, Dimitrios; LINARDOU, Helen et al.Journal of neuro-oncology. 2005, Vol 71, Num 1, pp 61-65, issn 0167-594X, 5 p.Article

Adjuvant chemotherapy using CPT-11, leucovorin plus bolus 5-fluorouracil and radiotherapy in patients with rectal cancer. A feasibility studyKALOFONOS, Haralabos P; KARDAMAKIS, Dimitrios; BAMIAS, Aristotelis et al.Anticancer research. 2003, Vol 23, Num 2C, pp 1687-1691, issn 0250-7005, 5 p.Article

Lapatinib plus capecitabine for HER2-positive advanced breast cancerGEYER, Charles E; FORSTER, John; SKARLOS, Dimosthenis et al.The New England journal of medicine. 2006, Vol 355, Num 26, pp 2733-2743, issn 0028-4793, 11 p.Article

Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: A randomized study conducted by the hellenic cooperative oncology groupFOUNTZILAS, George; PAPADIMITRIOU, Christos; PAPAKOSTAS, Pavlos et al.Journal of clinical oncology. 2001, Vol 19, Num 8, pp 2232-2239, issn 0732-183XArticle

Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trialPENTHEROUDAKIS, George; KALOGERAS, Konstantine T; SAMANTAS, Epaminondas et al.Breast cancer research and treatment. 2009, Vol 116, Num 1, pp 131-143, issn 0167-6806, 13 p.Article

The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer : A phase II feasibility study conducted by the Hellenic cooperative oncology groupSAMELIS, Georgios Fotios; KALOFONOS, Haralambos; ADAMOU, Adamos et al.Urology (Ridgewood, NJ). 2005, Vol 66, Num 2, pp 382-385, issn 0090-4295, 4 p.Article

Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer : a phase II study of the hellenic cooperative oncology group (HeCOG)CHRISTODOULOU, Christos; KALOFONOS, Haralambos P; BRIASOULIS, Evangelos et al.Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 2, pp 207-212, issn 0344-5704, 6 p.Article

Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II studySTATHOPOULOS, George P; RIGATOS, Sotiris K; CHRISTODOULOU, Christos et al.Cancer chemotherapy and pharmacology. 2004, Vol 54, Num 3, pp 259-264, issn 0344-5704, 6 p.Article

Two cycles of carboplatin-based adjuvant chemotherapy for high-risk clinical stage I and stage IM non-seminomatous germ cell tumours of the testis: A HECOG trialPECTASIDES, Dimitrios; SKARLOS, Dimosthenis; DIMOPOULOS, Athanasios-Meletios et al.Anticancer research. 2003, Vol 23, Num 5B, pp 4239-4244, issn 0250-7005, 6 p.Article

Greek BRCA1 and BRCA2 mutation spectrum : two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patientsKONSTANTOPOULOU, Irene; RAMPIAS, Theodore; KARANIKIOTIS, Charisios et al.Breast cancer research and treatment. 2008, Vol 107, Num 3, pp 431-441, issn 0167-6806, 11 p.Article

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab : updated efficacy and biomarker analysesCAMERON, David; CASEY, Michelle; CHAN, Arlene et al.Breast cancer research and treatment. 2008, Vol 112, Num 3, pp 533-543, issn 0167-6806, 11 p.Article

Metastatic breast cancer with liver metastases : a registry analysis of clinicopathologic, management and outcome characteristics of 500 womenPENTHEROUDAKIS, George; FOUNTZILAS, George; BAFALOUKOS, Dimitrios et al.Breast cancer research and treatment. 2006, Vol 97, Num 3, pp 237-244, issn 0167-6806, 8 p.Article

The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma : A phase II study of the hellenic cooperative oncology groupBAMIAS, Aristotle; MOULOPOULOS, Lia A; KALOFONOS, Haralambos P et al.Cancer. 2006, Vol 106, Num 2, pp 297-303, issn 0008-543X, 7 p.Article

Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer : a phase I/II study conducted by the hellenic cooperative oncology groupFOUNTZILAS, George; PECTASIDES, Dimitrios; MARKOPOULOS, Christos et al.Breast cancer research and treatment. 2005, Vol 92, Num 1, pp 1-9, issn 0167-6806, 9 p.Article

Tolerability of adjuvant High-dose interferon alfa-2b: 1 month versus 1 year-a hellenic Cooperative Oncology Group studyGOGAS, Helen; BAFALOUKOS, Dimitrios; FRANGIA, Konstantina et al.Anticancer research. 2004, Vol 24, Num 3B, pp 1947-1952, issn 0250-7005, 6 p.Article

Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: A Hellenic Cooperative Oncology Group (HeCOG) studyPECTASIDES, Dimitrios; PAPAXOINIS, George; KOSMIDIS, Paris et al.Oncology reports. 2012, Vol 27, Num 1, pp 216-224, issn 1021-335X, 9 p.Article

Vinorelbine versus Paclitaxel for Patients with Advanced Non-small Cell Lung Cancer (NSCLC) and a Performance Status of 2KOSMIDIS, Paris A; SYRIGOS, Konstantinos; FOUNTZILAS, George et al.Anticancer research. 2012, Vol 32, Num 1, pp 175-181, issn 0250-7005, 7 p., aArticle

Randomized Phase III Study of 1 Month Versus 1 Year of Adjuvant High-Dose Interferon Alfa-2b in Patients With Resected High-Risk MelanomaPECTASIDES, Dimitrios; DAFNI, Urania; PAPADOPOULOS, Othon et al.Journal of clinical oncology. 2009, Vol 27, Num 6, pp 939-944, issn 0732-183X, 6 p.Article

Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapyKOSTOPOULOS, Ioannis; ARAPANTONI-DADIOTI, Petroula; KYRKOU, Elisavet et al.Breast cancer research and treatment. 2006, Vol 96, Num 3, pp 251-261, issn 0167-6806, 11 p.Article

Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: A phase II study of the hellenic cooperative oncology groupDIMOPOULOS, Meletios A; PAPADIMITRIOU, Christos A; SARRIS, Kyrillos et al.Gynecologic oncology (Print). 2002, Vol 85, Num 3, pp 476-482, issn 0090-8258Article

Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: A phase III randomized trialKOSMIDIS, Paris; MYLONAKIS, Nick; PAPAKOSTAS, Pavlos et al.Journal of clinical oncology. 2002, Vol 20, Num 17, pp 3578-3585, issn 0732-183XArticle

Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology GroupSKARLOS, Dimosthenis-Vasilios; DIMOPOULOS, Athanassios-Meletios; SAMANTAS, Epaminondas et al.Lung cancer. 2003, Vol 41, Num 1, pp 107-111, issn 0169-5002, 5 p.Article

Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the hellenic cooperative oncology groupSKARLOS, Dimosthenis V; BAI, Maria; GOUSSIA, Anna et al.Anticancer research. 2007, Vol 27, Num 4C, pp 2973-2983, issn 0250-7005, 11 p.Article